| JYHB2100140 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-02-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-09-23 | view |
| JYHB2100141 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-02-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-09-23 | view |
| JXHS2000150 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-04-13 | view |
| JXHS2000151 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-04-13 | view |
| JXHL2100068 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-03-02 | view |
| JXHL2100067 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-03-02 | view |
| JYHB2002229 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2020-11-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-11-24 | view |
| JYHB2002228 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2020-11-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-11-24 | view |
| JXHL2000306 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-18 | view |
| JXHL2000305 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-18 | view |
| JYHB2001172 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-07-04 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-09-04 | view |
| JYHB2001171 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-07-04 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-09-04 | view |
| JYHB2000760 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-06-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-08-18 | view |
| JYHB2000759 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-06-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-08-18 | view |
| JYHB2000290 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-05-25 | view |
| JYHB2000291 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-05-25 | view |
| JXHL1900321 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-22 | | AstraZeneca AB | In Review | 2019-11-21 | view |
| JXHL1900320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-22 | | AstraZeneca AB | In Review | 2019-11-21 | view |
| JXHS1800054 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2018-10-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-03 | view |
| JXHS1800055 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2018-10-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-03 | view |
